[music]

Bloomberg Audio Studios podcasts, radio,

news.

>> The Stock Movers Report, your roundup of

companies making moves in the stock

market, harnessing the power of

Bloomberg data.

>> Let's take a [music] look at some of the

stocks on the move today in Europe. I'm

Rachel Evans with Caroline Heepka and

we're joined by Bloomberg reporter Tiwa

Adabio. Tiwa, Spanish natural gas enas

been making gains this morning. fill us

in on what's going on there.

>> Well, Rachel, as one of our equities

reporters at Bloomberg has put it, this

stock is soaring this morning. It's up

as much as 15%. So, Anagas imports,

stores, and transports natural gas. They

also operate plants across Spain. And

this uptick is a bit of a surprise. It

comes after the Spanish regulator

unveiled a draft proposal for gas

companies, which JP Morgan is saying is

unexpectedly positive. So according to

that analyst note under the new

proposals, Enagas could benefit from as

much as€ 650 million to€750 million

euros of incremental revenues and that's

just in the first year. So it really

does come as a boost to the stock

certainly amidst uncertain times uh for

importers and transporters of natural

gas like any gas as this conflict in the

Middle East continues to put pressure on

global energy supplies.

>> Yeah, absolutely. Meanwhile, a big win

for Astroenica after a key breakthrough

with a drug for lung disease. That's

right. So, Astroenica is near the top of

the Euro Stock 600 winners list this

morning. It's up just under 4% at the

highest. And the reason for this is

because of one of their experimental

drugs as you mentioned. It's used to

treat the deadly lung condition COPD.

That's chronic obstructive pulmonary

disease. Now, this drug has emerged from

two separate studies. Now, with results

showing that it brought statistically

significant reductions to flare-ups of

this condition, the thinking here from

analysts surveyed by Bloomberg is that

this new development could generate

sales of around $866 million

uh a year by 2032. And of course, these

results open up access to a broader,

more lucrative market here. But this is

a particularly big win for Astroenica

because similar products from its peers

like Safhi and Rash have disappointed in

this area. So potentially a first mover

advantage here. But our Bloomberg

intelligence analysts are warning to

perhaps proceed with caution here

because there was a bit of a lack of

detail in their original statement about

these results and Astroenica are still

yet to present this and its full

findings at an an upcoming medical

meeting.

>> Interesting. So the devil could be in

the detail there. Um meanwhile we've had

some M&A news in the alcoholic beverage

space. Tell us more.

>> So this deal has really been the talk of

the industry as far as beverages are

concerned over the last two days. Per

Rickard is reportedly in talks about a

potential acquisition of the owners of

the firm that uh creates Jack Daniels

whiskey. That's brown foreman. It's a

deal which could create the second

biggest player in the US market

according to analysts. So really

significant shares up as much as 4.2%

this morning. But there are questions

from some analysts. Deutsche Bank saying

they would be surprised if the

transaction actually did create material

value for shareholders, but some others

like Barclays saying it makes strategic

sense. So, we'll definitely keep

monitoring this one as those talks

progress, [music] but certainly two very

recognizable names within the sector.

>> The Stock Movers Report from Bloomberg

Radio. Check back with us throughout the

[music] day for the latest roundup of

companies making news on Wall Street.

And for the latest market moving

headlines, listen [music] to Bloomberg

Radio Live. Catch us on YouTube,

Bloomberg.com, and on Apple CarPlay

[music] and Android Auto with the

Bloomberg Business App.